Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:548951.
doi: 10.1155/2015/548951. Epub 2015 Apr 16.

Evaluation of high sensitive troponin in erectile dysfunction

Affiliations

Evaluation of high sensitive troponin in erectile dysfunction

Alessandra Barassi et al. Dis Markers. 2015.

Abstract

Background: Evidence is accumulating in favour of a link between erectile dysfunction (ED) and coronary artery diseases. We investigated the presence of cardiac injury in patients who have had arteriogenic and nonarteriogenic ED using the hs-Tn levels.

Methods: The diagnosis of ED was based on the International Index of Erectile Function 5-questionnaire (IIF-5) and patients were classified as arteriogenic (A-ED, n = 40), nonarteriogenic (NA-ED, n = 48), and borderline (BL-ED, n = 32) patients in relation to the results of echo-color-Doppler examination of cavernous arteries. The level of hs-TnT and hs-TnI was measured in 120 men with a history of ED of less than one year with no clinical evidence of cardiac ischemic disease.

Results: The levels of both hs-TnT and hs-TnI were within the reference range and there was no significant (P > 0.05) difference between patients of the three groups. The hs-CRP values were higher in A-ED men compared with NA-ED (P = 0.048) but not compared with BL-ED (P = 0.136) and negatively correlated with IIF-5 (r = -0.480; P = 0.031).

Conclusions: In ED patients of the three groups the measurement of hs-Tn allows us to exclude the presence of cardiac involvement at least when the history of ED is less than one year and the men are without atherosclerotic risk factors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Feldman H. A., Goldstein I., Hatzichristou D. G., Krane R. J., McKinlay J. B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology. 1994;151(1):54–61. - PubMed
    1. Aranda P., Ruilope L. M., Calvo C., Luque M., Coca A., de Miguel Á. G. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. American Journal of Hypertension. 2004;17(2):139–145. doi: 10.1016/j.amjhyper.2003.09.006. - DOI - PubMed
    1. Roumeguère T., Wespes E., Carpentier Y., Hoffmann P., Schulman C. C. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. European Urology. 2003;44(3):355–359. doi: 10.1016/S0302-2838(03)00306-3. - DOI - PubMed
    1. Beutel M. E., Wiltink J., Hauck E. W., et al. Correlations between hormones, physical, and affective parameters in aging urologic outpatients. European Urology. 2005;47(6):749–755. doi: 10.1016/j.eururo.2005.02.015. - DOI - PubMed
    1. Maas R., Schwedhelm E., Albsmeier J., Böger R. H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vascular Medicine. 2002;7(3):213–225. doi: 10.1191/1358863x02vm429ra. - DOI - PubMed